Form 4: OraSure Technologies Executive Receives Stock Grant, Pays Taxes with Shares

Kathleen Gallagher Weber, Chief Product Officer of OraSure Technologies, received a restricted stock award and used shares to cover the associated tax liability.

Summary

• Kathleen Gallagher Weber, Chief Product Officer of OraSure Technologies, received a grant of 88,148 shares of restricted stock on March 1, 2025.
• These shares vest in three equal annual installments starting March 1, 2026, contingent upon continuous service.
• Weber also disposed of 8,312 shares on March 1, 2025, at a price of $3.6275 to cover the tax liability related to the vesting of restricted shares.
• Following these transactions, Weber directly owns 391,206 shares of OraSure Technologies stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The stock grant is a positive sign of confidence in the executive and the company, while the tax-related share disposal is a routine transaction.

Positives

• The grant of restricted stock aligns the executive's interests with those of the shareholders, incentivizing continued service and performance.

Risks

• The vesting of the restricted stock is contingent upon continuous service, meaning Weber must remain employed by OraSure Technologies to fully realize the benefit.

Future Outlook

The executive's future compensation is tied to the company's performance through the vesting of restricted stock, incentivizing growth and stability.

Industry Context

Stock grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the stock grant as a positive sign, aligning executive interests with company performance.
• Employees may see the grant as a sign of the company's commitment to its leadership.

Key Dates